🟢 Philip Morris International is trading 3.25% up today following FDA Modified Risk Tobacco Product authorization for Zyn.

Philip Morris International is trading 3.25% up at $186.79 today. The company continues to see positive sentiment following the U.S. Food and Drug Administration's (FDA) authorization on June 30, 2026, to market 20 variants of its Zyn nicotine pouches as Modified Risk Tobacco Products (MRTPs).

• This landmark decision allows PMI to claim that using Zyn instead of cigarettes puts consumers at a lower risk of several smoking-related diseases.
• The authorization represents a significant regulatory victory for PMI's smokeless business and strengthens the long-term outlook for its smoke-free product portfolio.